Cecilia Oliyai
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Oncology
- Biomaterials
- Pharmaceutical Science top 10%
- Co-authors
- Ronald T. BorchardtThomas J. LoblAndré TrouetDan ShochatKim Van derpoortenVincent DuboisA. PassioukovJorge Abarca‐Quinones
- Topics
- Protein purification and stability (4 papers)Botulinum Toxin and Related Neurological Disorders (3 papers)Chemical Synthesis and Analysis (2 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Cecilia Oliyai
12 papers receiving 404 citations
Peers
Comparison fields: 5 of 62
- Molecular Biology 307
- Radiology, Nuclear Medicine and Imaging 125
- Oncology 67
- Biomaterials 58
- Pharmaceutical Science 44
Countries citing papers authored by Cecilia Oliyai
This map shows the geographic impact of Cecilia Oliyai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Oliyai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Oliyai more than expected).
Fields of papers citing papers by Cecilia Oliyai
This network shows the impact of papers produced by Cecilia Oliyai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Oliyai. The network helps show where Cecilia Oliyai may publish in the future.
Co-authorship network of co-authors of Cecilia Oliyai
This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Oliyai. A scholar is included among the top collaborators of Cecilia Oliyai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Oliyai. Cecilia Oliyai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 8 | |
| 4 | 9 | |
| 5 | CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity. | 26 |
| 6 | Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies. | 55 |
| 7 | 60 | |
| 8 | 4 | |
| 9 | 45 | |
| 10 | 69 | |
| 11 | Solid state chemical instability of an asparaginyl residue in a model hexapeptide. | 17 |
| 12 | 126 |
About Cecilia Oliyai
Cecilia Oliyai is a scholar working on Neurology, Biophysics and Pharmaceutical Science, having authored 12 papers that have together received 425 indexed citations. Recurring topics across this work include Protein purification and stability (4 papers), Botulinum Toxin and Related Neurological Disorders (3 papers) and Chemical Synthesis and Analysis (2 papers). The work is most often cited by research in Pharmaceutical Science (44 citations), Radiology, Nuclear Medicine and Imaging (125 citations) and Molecular Biology (307 citations). Cecilia Oliyai has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Ronald T. Borchardt, Thomas J. Lobl, André Trouet, Dan Shochat, Kim Van derpoorten, Vincent Dubois, A. Passioukov, Jorge Abarca‐Quinones, R. Baurain and Sanjeev Gangwar. Their work appears in journals such as Journal of Medicinal Chemistry, Pharmaceutical Research and Toxicon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.